Healthcare - Biotechnology - NYSE - US
$ 6.84
-1.87 %
$ 94.4 M
Market Cap
-1.72
P/E
Price Target
Average
275.24%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
29.87%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Annovis Bio, Inc.
Wall Street analysts predict an average 1-year price target for ANVS of $25.7 , with forecasts ranging from a low of $21 to a high of $30 .
ANVS Lowest Price Target
Wall Street Target
21 USD
207.02%
ANVS Average Price Target
Wall Street Target
25.7 USD
275.24%
ANVS Highest Price Target
Wall Street Target
30 USD
338.60%
REVENUE FORECAST
Revenue Forecast Chart ANVS
EBIT FORECAST
EBIT Forecast Chart ANVS
NET INCOME FORECAST
Net Income Chart ANVS